Our science and regulatory affairs tracks will provide up-to-date insight and context to today’s developments and trends so you can better navigate the twists and turns of the regulatory landscape for generic and biosimilar drug applications. You will have the opportunity to hear from subject matter experts, as well as engage with them and other experts from FDA, industry, and academia, to better inform your business strategies and optimize your results.
*Topics are subject to change
Possible job titles include:
Regulatory Affairs, Medical Affairs, Business Development, Program Management, Policy, Commercial Development, Scientific Affairs, Research Analyst
GRx+Biosims™ 2024 is the leading regulatory science and policy event for the U.S. generics and biosimilars industry. Get the latest information directly from Food and Drug Administration experts, understand the latest policy that impacts the industry and gain valuable insights to advance your professional development
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington, DC 20001
P: 202.249.7100
E: [email protected]
Association for Accessible Medicines
Biosimilars Council